439
Views
25
CrossRef citations to date
0
Altmetric
Articles

The regulatory role of nerve growth factor and its receptor system in fibroblast‐like synovial cells

&
Pages 207-215 | Accepted 03 Sep 2008, Published online: 13 Aug 2009
 

Abstract

Objectives: Investigating the role of nerve growth factor (NGF) and its receptors (NGF‐R) in inflammatory diseases is an active field of research. Inflammatory diseases of the joint are the commonest cause of human morbidity but very little is known about the effect of NGF on synovial tissue biology. Here we have studied NGF/NGF‐R and their functional significance on cultured fibroblast‐like synovial cells (FLS) collected from the synovial tissue of five healthy subjects.

Methods: NGF/NGF‐R expression was determined in the basal condition and after stimulation with tumour necrosis factor (TNF)α and interleukin (IL)‐1β by enzyme‐linked immunosorbent assay (ELISA) and fluorescence‐activated cell sorting (FACS). Proliferation studies were performed by cell count, hexosaminidase assay, and the MTT assay. The synovial fluid (SF) NGF level was studied by ELISA in 12 psoriatic arthritis (PsA), 14 rheumatoid arthritis (RA), and 10 osteoarthritis (OA) patients.

Results: FACS studies showed that unstimulated FLS expressed low levels of NGF and the high‐affinity NGF‐tyrosine kinase receptor TrkA, and TNFα and IL‐1β increased NGF and TrkA expression in FLS. NGF (100 ng/mL) increased FLS proliferation by 400% compared to the control (medium only). The NGF level was significantly higher in the PsA group (365.5±85.2 pg/mL) than in the RA (120±35 pg/mL) and OA groups (30±6 pg/mL).

Conclusions: Upregulation of NGF/TrkA in proinflammatory cytokine‐activated FLS, the mitogenic effect of NGF on FLS, and the increased NGF level in SF of inflammatory arthritis suggest that there is cross‐talk between NGF/NGF‐R and FLS. These results also suggest that dysregulated production of NGF may lead to synovial cell proliferation and thus could influence the inflammatory and proliferative cascades of inflammatory arthritis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.